Morimatsu International Holdings Company Limited provided financial guidance for the year ended 31 December 2022. For the period, the company expected the consolidated revenue of the Group for the Reporting Period will record an increase of not less than 50% as compared to the corresponding period last year. Such expected increase is mainly attributable to the significant increase in orders from the pharmaceutical, raw materials of power battery (including mining and metallurgy) and electronic chemicals industries/fields; and (ii) the consolidated net profit of the Group for the Reporting Period will record an increase of not less than 70% as compared to the corresponding period last year.

Such expected increase is mainly attributable to the significant increase in revenue as a result of the expansion of the business scale of the Group and the enhanced production capacity.